CLINICAL_TRIALS trial_result · 2012-03-02

Clinical Trial Update: A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]

Phase 2 study of MP-376 in chronic obstructive pulmonary disease to prevent acute exacerbations has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Amgen | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-03-02